NASDAQ:CELG
$55.22
(2/9 11:29AM)
+0.8%
| Open | $55.34 |
Mkt Cap | $25.2 Billion |
| High | $55.69 |
52Wk High | $59.67 |
| Low | $54.96 |
52Wk Low | $36.90 |
| Volume | 960,224 |
Avg Vol 10D | 3.4 Million |
Ockham's Rating/Recommendation Summary
Rating specific information requires Premium Access.
Buy Now
or
Learn More about Ockham's Features and Services.
CELG Revenue
For a long time, value investors have used the current share price relative to sales per share levels as an important valuation tool. We utilize a historical weighted average methodology that treats recent years more importantly in the calculation. When looking at CELG through this framework, we can see that our weighted average historical high and low Price to Sales per share ratios over the last 10 years are 19.28x and 9.89x respectively.
Utilizing this range we can see that CELG’s current Price to Sales per share ratio of 9.43x is significantly below its average levels historically. In fact, with a current price of $55.16, CELG is a full 36% below its average Price to Sales ratio at comparable sales levels. This is a rare occurrence and, when taken in context of the other areas of our analysis, can be a strong positive for our outlook for CELG.
CELG Cash Earnings
Looking at CELG specifically in their Cash Earnings capabilities, Ockham views CELG as significantly below their historical average multiples of Cash Earnings, as calculated by our proprietary analysis. It is incredibly important to understand that for CELG, the current level of Cash Earnings compared to its historical levels helps identify where CELG is in relation to what the investing community was willing to pay for this level of Cash Earnings in the past. With a historical high Cash Earnings per share ratio of 88.42 and a historical low Cash Earnings per share ratio of 55.42, an investor can relate where value becomes optimal.
So what does "significantly below" mean when we talk about Price to Cash Earnings numbers for CELG? From the Ockham perspective, we are looking specifically at CELG to see if the market is recognizing the huge disparity between CELG's past stock price to Cash Earnings ratio to today's levels. At a difference of 32% below the average historical Price to Cash Earnings ratio, our view would be quite positive at this point. However, as with all metrics, we need to also take other factors into account when looking at CELG. While we view better Cash Earnings metrics as very important, if the market is slow to identify this value, or if Cash Earnings were to fall from these levels, we would become more neutral in our stance.
CELG Dividends
A strong dividend payment history is looked upon as a favorable characteristic on a company’s future and potentially can receive a positive Ockham rating. That being said, we don't require dividend payments for company's whose management has elected to forgo them entirely. Although they may currently pay a dividend, our data source has no historical record of it for CELG. Since we cannot apply our historical trend analysis to dividends for CELG we have a neutral score for the dividend portion of our analysis.
The Outlook for Emerging Markets and Celgene Corporation Discussed on Fast Money
There is no doubt that the emerging markets are where the growth is right now. The latest news mention of CELG on Fast Money was in relation to emerging markets.
As we analyze the results from RazorWire, one thing we do is rank each stock in terms of amount of news coverage. Recently, CELG has been less covered in the news compared to the rest of our universe of stocks. The Motley Fool CAPS data suggests that investors believe Celgene Corporation will beat the market in the foreseeable future. We consider CELG as Undervalued at the current price of $56.89. According to our methodology, this stock has appreciation potential based on current fundamentals which only improves if earnings or revenue surprise.
“… I lover CELGENE, love what they have done since they reported. CELGENE and amgen, the two names that I would look at. > > …”
Celgene Corporation News is Being Covered Right Now on Seeking Alpha Wall St Breakfast
Celgene Corporation is one of the thousands of companies that Ockham has news analytics on, and it was recently discussed on Seeking Alpha Wall St Breakfast.
Crowd sentiment is favorable on this stock, as measured by the Motley Fool CAPS survey. Take notice of the news on this stock because it is up $2.95 since the close of trading yesterday. In comparison to the other stocks that we follow, Celgene Corporation has seen more discussion in relation to its normal ranking among the group. Be aware that the news sources we track are focusing on this stock more often these days. At present, Ockham has a valuation stance of Undervalued on CELG, as we could see significant price appreciation based on current fundamentals like cash earnings and revenue.
“… PM 7-Yr Note Auction4:30 PM Fed Balance Sheet4:30 PM Money Supply Notable earnings before Thursday's open: AEP, AUO, AVT, BAX, BDX, BEN, BMY, CAH, CELG, CHKP, CL, CNX, CY, D, ... …”
Fast Money: Discussion of CELG's Earnings
Earnings are one of the most important fundamental factors we track, so we are always interested in the latest profit reports and news.
Based on our methodology, Celgene Corporation should hold some appeal to value investors as we view it as Undervalued. Crowd sentiment is leaning to the bearish side, according to the robust data set collected by the Motley Fool CAPS survey. Ranking all stocks in terms of news coverage offers some interesting data. In the case of CELG, it is getting significantly more attention in recent news coverage than we are used to seeing.
“… CELGENE. > > karen? > > transocean. Rigs. > > got to go with amgen. This son of a gun's going higher. > > thanks for watching. …”
Fast Money Has News on CELG
The latest news from business television and influential blogs is always available through Ockham's RazorWire, and this news is in relation to Celgene Corporation.
At present, Ockham has a valuation stance of Undervalued on CELG, as we could see significant price appreciation based on current fundamentals like cash earnings and revenue. When taking into account the amount of news coverage each stock normally sees as a percentage of the total, Celgene Corporation has actually sunk a bit in comparison to the others. Crowd sentiment is favorable on this stock, as measured by the Motley Fool CAPS survey.
“… trade. Let's go around the horn. Joe? >> the british pound trade. >> CELGENE. >> sell bcr. >> buy watson pharmaceutical. …”
Yearly Highs and CELG Recently Discussed on Fast Money
When a stock reaches a notable high point, investors have to ask themselves: take profits or let it run? See what Fast Money recommends for Celgene Corporation and obviously Ockham has an opinion as well.
When taking into account the amount of news coverage each stock normally sees as a percentage of the total, Celgene Corporation has actually sunk a bit in comparison to the others. At present, Ockham has a valuation stance of Undervalued on CELG, as we could see significant price appreciation based on current fundamentals like cash earnings and revenue. Crowd sentiment is favorable on this stock, as measured by the Motley Fool CAPS survey.
“… I think CELGENE is a buy here. > > when you look at the health care space you're seeing an allocation of capital to a sector that underperformed last year. …”
News Breaking on Celgene Corporation on Closing Bell
The latest news from Closing Bell on CELG is available through Ockham's news analytics platform RazorWire.
Based on our methodology, Celgene Corporation should hold some appeal to value investors as we view it as Undervalued. We noticed recently that in comparison to all other stocks we analyze in the news; CELG has received less coverage from the financial media in business television and blogs. Crowd sentiment is leaning to the bearish side, according to the robust data set collected by the Motley Fool CAPS survey.
“… CELGENE came out today and upgra upgraded. It has since come back. It's up about half a percent right now and again the nasdaq. …”
Celgene Corporation News Appeared on Street Signs
The latest news from business television and influential blogs is always available through Ockham's RazorWire, and this news is in relation to Celgene Corporation.
In comparison to the other stocks that we follow, Celgene Corporation has seen more discussion in relation to its normal ranking among the group. Be aware that the news sources we track are focusing on this stock more often these days. Crowd sentiment is favorable on this stock, as measured by the Motley Fool CAPS survey. At present, Ockham has a valuation stance of Undervalued on CELG, as we could see significant price appreciation based on current fundamentals like cash earnings and revenue.
“… Quickly, before we go, CELGENE. > > a classic misdirection play. They come out, guide low somewhere people freak out. Stock gets down. …”
Power Lunch: What is Happening with Celgene Corporation Now?
News has broken via the television and viral blogs regarding CELG, so investors should take an interest in learning what was said.
When taking into account the amount of news coverage each stock normally sees as a percentage of the total, Celgene Corporation has actually sunk a bit in comparison to the others. Take notice of the news on this stock because it is up $5.13 since the close of trading yesterday. At present, Ockham has a valuation stance of Undervalued on CELG, as we could see significant price appreciation based on current fundamentals like cash earnings and revenue. However, this stock has already had a pretty good week, making it less attractive to value investors at the current price. Crowd sentiment is favorable on this stock, as measured by the Motley Fool CAPS survey.
“… CELGENE up. Maybe the interview 24 hours ago meeting with investors and analysts did a little bit of good because his stock is up 1. 3%. …”
Power Lunch Discussed the Latest Development of Celgene Corporation
Staying informed on the news is invaluable for investors, and RazorWire has captured a recently discussion on CELG from Power Lunch.
The latest news on CELG has created quite a stir as the stock is trading $4.85 higher in today's session. Based on our methodology, Celgene Corporation should hold some appeal to value investors as we view it as Undervalued as of this week's report. With the price now up to $55.47, we may consider downgrading the stock's valuation coming into next week. Crowd sentiment is leaning to the bearish side, according to the robust data set collected by the Motley Fool CAPS survey. We noticed recently that in comparison to all other stocks we analyze in the news; CELG has received less coverage from the financial media in business television and blogs.
“… A big one of a CELGENE drug was stopped early. That might sound counterintuitive, but the fact is it was stopped early because the drug was working so well and that's why the ... …”
News Developing on The Call for CELG
News has broken via the television and viral blogs regarding CELG, so investors should take an interest in learning what was said.
The Motley Fool CAPS data suggests that investors believe Celgene Corporation will beat the market in the foreseeable future. We noticed recently that in comparison to all other stocks we analyze in the news; CELG has received less coverage from the financial media in business television and blogs. Based on our methodology, Celgene Corporation should hold some appeal to value investors as we view it as Undervalued as of this week's report. With the price now up to $55.78, we may consider downgrading the stock's valuation coming into next week. The latest news on CELG has created quite a stir as the stock is trading $5.16 higher in today's session.
“… 2% so outpacing the market's gains in large part due to CELGENE up 10% because they stopped a big study early because patients with the blood cancer were doing so well on one of ... …”